NVET

Nexvet Biopharma plc Ordinary Shares
NVET

Delisted

NVET was delisted on the 28th of July, 2017.

Back to rankings

15 hedge funds and large institutions have $26.7M invested in Nexvet Biopharma plc Ordinary Shares in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$173K
2
+$57.3K

Top Sellers

1
-$105K
2
-$14.3K
3
-$9.69K
4
UBS Group
UBS Group
Switzerland
-$4K
5
TRCT
Tower Research Capital (TRC)
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$12.3M
2
$4.64M
3
$4.18M
4
$4.06M
5
$720K
6
$206K
7
$173K
8
$164K
9
$128K
10
$56K
11
$27K
12
$18K
13
$5K
14
$3K
15
–
16
–
17
–